Clinical Efficacy of a Supplement on Sleep Quality

NCT04988542 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-08-11

No results posted yet for this study

Summary

This is a prospective randomized clinical study of 30 patients to evaluate a novel sleep supplement. This study will be evaluating the effectiveness of the supplement over a 2 month program. The study will assess the effects that the supplement has on a patient's sleep metrics and epigenetic age biomarkers.

Conditions

  • Sleep

Interventions

DIETARY_SUPPLEMENT

Circadian Wellness sleep SL strip

Participants in the intervention group will be asked to begin Circadian Wellness sleep SL strip nightly for 30 days. Participants will continue the supplementation for the 30 days.

Sponsors & Collaborators

  • Circadian Wellness Corp

    collaborator UNKNOWN
  • TruDiagnostic

    lead INDUSTRY

Principal Investigators

  • Sanjeev Goel · Peak Human Labs

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2021-12-31
Completion
2022-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04988542 on ClinicalTrials.gov